Cytokines and reperfusion injury

Neurology

Volumn 49, Issue 5 SUPPL., 1997, Pages

  Clark, Wayne M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATION; LEUKOCYTE ADHERENCE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STROKE;

EID: 0030689650     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.49.5_suppl_4.s10     Document Type: Article

References (59)

1. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992;263:C1-16.
2. Feuerstein GZ, Wang X, Yue TL, Barone FC. Inflammatory cytokines and stroke: emerging new strategies for stroke therapeutics. In: Moskowitz MA, Caplan LR, eds. Cerebrovascular diseases: Nineteenth Princeton Stroke Conference. Newton, MA: Butterworth-Heinemann, 1995:75-91.
3. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J Neurochem 1991;58:390-392.
4. Fassbender K, Rossol S, Kammer T, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994;122:135-139.
5. Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995;26:1393-1398.
6. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992;23:1367-1379.
7. Clark WM, Madden KP, Rothlein R, Zivin JA. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J Neurosurg 1991;75: 623-627.
8. Clark WM, Madden KP, Rothlein R, Zivin JA. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 1991;22:877-883.
9. Sei Y, Vitkovic L, Yokoyama MM. Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. NeuroImmuno Modulation 1995;2:121-133.
10. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
11. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993;269:1829-1835.
12. Fisher CJJ, Slotman GJ, Opal S, et al. Interleukin-1 receptor antagonist reduces mortality in patients with sepsis syndrome. Presented at the fourth annual meeting of the American College of Chest Physicians, November 4, 1991, San Francisco, CA.
13. McCarthy PL, Abhyankar S, Neben S, et al. Inhibition of interleukin-1 by interleukin-1 receptor antagonist prevents graft versus host disease. Blood 1991;78:1915-1918.
14. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550-552.
15. Aiura K, Gelfand JA, Wakabayashi G, et al. Interleukin-1 receptor antagonist blocks staphylococcal induced shock in rabbits. Cytokine 1991;3:498.
16. Gershenwald JE, Fong YM, Fahey TJ III, et al. Interleukin-1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 1990;87:4966-4970.
17. Di Santo E, Sironi M, Pozzi P, et al. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1β production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis. NeuroImmuno Modulation 1995;2:149-154.
18. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 1995; 18:130-136.
19. Rothwell N. Functions and mechanism of IL-1 in the brain. Trends Pharmacol Sci 1991;12:430-435.
20. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor expression in ischemic neurons. Stroke 1994;25:1481-1488.
21. Wang XK, Yue T-L, Barone FC, White RF, Gagnon RC, Feuerstein GZ. Concommitant cortical expression of TNF-α and IL-1β mRNA following transient focal ischemia. Mol Chem Neuropathol 1994;23:103-114.
22. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995;26:676-681.
23. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992;29:243-246.
24. Garcia JH, Liu KF, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 1995;147:1477-1486.
25. Relton J, Martin D, Thompson R, Russel D. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol 1996;138:206-213.
26. Sharief M, Hentges R. Association between TNFα and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-472.
27. Wang X, Yue T, Barone F. Concommitant cortical expression of TNFα mRNA following transient focal ischemia. Mol Chem Neuropathol 1994;23:103-114.
28. Chao C, Ehrlich L, Peterson P. IL-1 and TNFα synergistically mediate neurotoxicity. Brain Behav Immun 1995;374:647-650.
29. Bruce A, Boling W, Kindy M, et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med 1996;2:788-794.
30. Ulrich A, Schlessinger J. Characterization and expression of interleukin-6. Cell 1990;61:203-212.
31. Baumann M, Baumann H, Fey G. Molecular cloning, characterization and functional expression of the rat liver interleukin 6 receptor. J Biol Chem 1990;265:19853-19862.
32. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
33. Mathiesen T, Andersson B, Loftenus A, von Holst H. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 1993;78:562-567.
34. Yan HQ, Banos MA, Herregodts P, Hooghe R, Hooghe-Peters EL. Expression of interleukin (IL)-1β, IL-6 and their respective receptors in the normal rat brain and after injury. Eur J Immunol 1992;22:2963-2971.
35. Higgins GA, Olschowska JA. Induction of interleukin-1β mRNA in adult rat brain. Mol Brain Res 1991;9:143-148.
36. Griffin WST, Stanley LC, Ling C, et al. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1986;7611.
37. Merrill JE, Strom SR, Ellison GW, Myers LW. In vitro study of mediators of inflammation in multiple sclerosis. J Clin Immunol 1989;9:84-96.
38. Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990;33:644-649.
39. Gijbels K, VanDamme J, Proost P, Put W, Carton H, Billiau A. Interleukin-6 production in the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol 1990;20:233-235.
40. Wang X, Yue T-L, Young PR, Barone FC, Feuerstein GZ. Expression of interleukin-6, c-fos, and zif268 MRNA in rat ischemic cortex. J Cereb Blood Flow Metab 1995;15:166-171.
41. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F. Increase in IL-6, IL-1, and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral type (p site) benzodiazepine liquid. J Neuroimmunol 1993;42:177-185.
42. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Stroke 1995;92:1866-1875.
43. Clark W, Lauten J, Coull B, Cherry N, Woodward W. ICAM-1 and IL-6 changes in the hippocampus following transient forebrain ischemia in the rat. Proc Soc Neurosci 1993;19:1664.
44. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995;37:800-804.
45. Clark W, Hazel JS, Beamer N, Wynn M, Coull B. The initial acute phase response predicts long term stroke recovery. Stroke 1996;27:186.
46. Kim J, Sung Y, Kim Y, Ryu J. Serial measurement of interleukin-6, transforming growth factor, and S-100 protein in patients with acute stroke. Stroke 1996;27:1553-1557.
47. Coull B, Beamer N, Clark W. Elevated plasma interleukin-6 in acute stroke. Stroke 1993;24:183.
48. Toulmond S, Vige X, Fage D, Benavides J. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett 1992;144:49-52.
49. Campbell IL, Abraham CR, Masliah E, et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci USA 1993;90:10061-10065.
50. Rothwell NJ, Relton JK. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Biobehav Rev 1992; 17:217-227.
51. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines. J Immunol 1990;144:129-135.
52. Zhang R, Chopp M, Jiang N, et al. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 1995;26:1438-1443.
53. Frohman EM, Frohman TC, Dustin ML, et al. The induction of intracellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-γ, tumor necrosis factor α, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J Neuroimmunol 1989;23:117-124.
54. Pober JS, Gimbrone MA, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon. J Immunol 1986;137:1893-1896.
55. Youker KA, Smith CW, Anderson DC, et al. Neutrophil adherence to isolated adult cardiac myocytes: induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest 1992;89:602-609.
56. Chung IY, Benveniste EN. TNF-α production by astrocytes: induction by lipopolysaccharide, interferon-gamma and interleukin-1. J Immunol 1990;144:2999-3007.
57. Lieberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989;867:6348-6352.
58. Clark WM, Lauten JD, Beamer NB, Coull BM. Cytokine and superoxide production in clinical stroke. J Stroke Cerebrovasc Dis 1995;5:166-171.
59. Clark WM, Lauten JD, Lessov N, Woodward W, Coull BM. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol Chem Neuropathol 1995;26:213-230.